This company is engaged in the development,_manufacture, and distribution of allograft and xenograft regenerative products. The company was_established in DATE, and has its_registered_head office in LOCATION_LOCATION_LOCATION_LOCATION COUNTRY COUNTRY COUNTRY. The company specialises in development,_manufacturing, and distribution of allograft and xenograft regenerative products, including acellular dermal matrices for skin, cartilage, and nerve tissue applications. Its_product_portfolio spans human tissue implants (e.g., MegaDerm, MegaCarti, MegaNerve Prime), cosmetic and pharmaceutical formulations, and related medical_devices, all produced in ISO and GMPcertified facilities. Beyond product development, it offers contract research and manufacturing services, while expanding globally through clinical approvals (such_as in COUNTRY) and strategic operations in COUNTRY and other markets.